The DOI matches its Crossref record; 111 of the 112 references it cites were found in a registry or an index.
Brain stress systems in the amygdala and addiction
Open accessAbstract
Dysregulation of the brain emotional systems that mediate arousal and stress is a key component of the pathophysiology of drug addiction. Drug addiction is a chronically relapsing disorder characterized by a compulsion to seek and take drugs and the development of dependence and manifestation of a negative emotional state when the drug is removed. Activation of brain stress systems is hypothesized to be a key element of the negative emotional state produced by dependence that drives drug-seeking through negative reinforcement mechanisms. The focus of the present review is on the role of two key brain arousal/stress systems in the development of dependence. Emphasis is placed on the neuropharmacological actions of corticotropin-releasing factor (CRF) and norepinephrine in extrahypothalamic systems in the extended amygdala, including the central nucleus of the amygdala, bed nucleus of the stria terminalis, and a transition area in the shell of the nucleus accumbens. Compelling evidence argues that these brain stress systems, a heretofore largely neglected component of dependence and addiction, play a key role in engaging the transition to dependence and maintaining dependence once it is initiated. Understanding the role of the brain stress and anti-stress systems in addiction not only provides insight into the neurobiology of the "dark side" of addiction but also provides insight into the organization and function of basic brain emotional circuitry that guides motivated behavior.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The distress and negative emotions of withdrawal are associated on the one hand with reduced dopamine signaling in response to rewards (anhedonia) and on the other with an enhanced sensitiv ity of the brain's stress system, including the extended amygdala, habenula and hypothalamus 66 .”
From Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention (2023) · cites this paper as [66]
Experimental — accuracy not yet measuredIn the citing paper
“Recruitment of brain stress amygdale activation has been suggested to cause the negative motivational state that drives addicitoin (Koob, 2009).”
From Impulsivity, frontal lobes and risk for addiction (2009) · cites this paper as Koob, 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
A Syndrome produced by Diverse Nocuous Agents
Selye, H. (1936) · Nature · doi:10.1038/138032a0 · Cited by 3,967
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Self-citationDrug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
Self-citationSwanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (2008) · Neuroendocrinology · doi:10.1159/000123454 · Cited by 1,953
The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress
Smith, S. M., & Vale, W. W. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.4/ssmith · Cited by 1,948
The reinstatement model of drug relapse: history, methodology and major findings
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615
Addiction and the brain antireward system
Koob, G. F., & Le Moal, M. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.103006.093548 · Cited by 1,457
Self-citationAllostasis: A New Paradigm to Explain Arousal Pathology
Sterling, P., & Eyer, J. (1988) · Zenodo · doi:10.5281/zenodo.13537700 · Cited by 1,450
Handbook of Life Stress, Cognition and Health
PASTOR, L. H. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.10.1347 · Cited by 1,402
Flagged first, then by citations
1 of the 112 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 389
Martínez‐Navarro, M., Lara-Mayorga, I. M., Negrete, R., Bilecki, W., Wawrzczak‐Bargieła, A., Gonçalves, L., Dickenson, A. H., Przewłocki, R., Baños, J.-E., & Maldonado, R. J. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.01.012 · Cited by 18
Petrie, G. N., Wills, K. L., Piscitelli, F., Smoum, R., Limebeer, C. L., Rock, E. M., Humphrey, A. E., Sheppard-Perkins, M. D., Lichtman, A. H., Mechoulam, R., et al. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05237-9 · Cited by 19
Bono, B. S. M., Ly, N. K. K., Miller, P. A., Williams-Ikhenoba, J. G., Dumiaty, Y., & Chee, M. J. S. (2022) · The Journal of Comparative Neurology · doi:10.1002/cne.25306 · Cited by 19
de Guglielmo, G., Simpson, S., Kimbrough, A., Conlisk, D., Baker, R., Cantor, M., Kallupi, M., & George, O. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109309 · Cited by 18
Klimkiewicz, A., Klimkiewicz, J., Jakubczyk, A., Kieres-Salomoński, I., & Wojnar, M. (2015) · Psychiatria Polska · doi:10.12740/pp/26071 · Cited by 17
Pourhamzeh, M., Mozafari, R., Jamali, S., Motamedi, F., Ahadi, R., & Haghparast, A. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112155 · Cited by 18
Silberman, Y., Fetterly, T. L., Awad, E. K., Milano, E. J., Usdin, T. B., & Winder, D. G. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12881 · Cited by 17
Methyleugenol Potentiates Central Amygdala GABAergic Inhibition and Reduces Anxiety
Liu, Y., Fan, H.-R., Deng, S., Zhu, T., Yan, Y., Ge, W., Li, W., & Li, F. R. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.250779 · Cited by 17
Tarai, S., Mukherjee, R., Gupta, S., Rizvanov, A. A., Palotás, A., Pammi, V. S. C., & Bit, A. (2019) · Cognitive Neurodynamics · doi:10.1007/s11571-019-09522-3 · Cited by 16
Verplaetse, T. L., Peltier, M. R., Roberts, W., Pittman, B. P., & McKee, S. A. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2020.106815 · Cited by 17
Baidoo, N., Wolter, M., Holahan, M. R., Epp, T., Winters, B. D., & Leri, F. (2020) · Addiction Biology · doi:10.1111/adb.12909 · Cited by 15
Borruto, A. M., Fotio, Y., Stopponi, S., Petrella, M., Carlo, S. D., Domi, A., Ubaldi, M., Weiss, F., & Ciccocioppo, R. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01096-1 · Cited by 17
Omega-3 Fatty Acids and Vulnerability to Addiction: Reviewing Preclinical and Clinical Evidence
Darcey, V. L., & Serafine, K. M. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200429094158 · Cited by 14
Zill, P., Vielsmeier, V., Büttner, A., Eisenmenger, W., Siedler, F., Scheffer, B., Möller, H. ‐., & Bondy, B. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0129-7 · Cited by 15
Kennett, A., Heal, D. J., & Wonnacott, S. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts128 · Cited by 15
Chou, Y., Hor, C. C., Lee, M. T., Lee, H., Guerrini, R., Calò, G., & Chiou, L. (2020) · Addiction Biology · doi:10.1111/adb.12971 · Cited by 15
Liu, X. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3838-1 · Cited by 15
Blum, K., Chen, A. L., Chen, T. J., Bowirrat, A., Waite, R. L., Kerner, M., Blum, S. H., Downs, B. W., Rhoades, P., Reinking, J. L., et al. (2009) · Cited by 15
Kaag, A. M., Levar, N., Woutersen, K., Homberg, J. R., van den Brink, W., Reneman, L., & van Wingen, G. A. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15040433 · Cited by 19
The Potential Role of Glucocorticoids and the HPA Axis in Alcohol Dependence
Stephens, M. A. C., McCaul, M. E., & Wand, G. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405941-2.00021-3 · Cited by 19
Maremmani, A. G. I., Maiello, M., Carbone, M. G., Pallucchini, A., Brizzi, F., Belcari, I., Conversano, C., Perugi, G., & Maremmani, I. (2017) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2017.10.001 · Cited by 15
Sokol, R., Albanese, M., Chew, A., Early, J., Grossman, E., Roll, D., Sawin, G., Wu, D. J., & Schuman-Olivier, Z. (2019) · Addiction Science & Clinical Practice · doi:10.1186/s13722-019-0176-y · Cited by 14
Jacques, D. T., Sturge‐Apple, M. L., Davies, P. T., & Cicchetti, D. (2019) · Development and Psychopathology · doi:10.1017/s0954579419001445 · Cited by 14
Involvement of the Dorsal Vagal Complex in Alcohol-Related Behaviors
Keller, B. N., Hajnal, A. S., Browning, K. N., Arnold, A. C., & Silberman, Y. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.801825 · Cited by 16
Investigational drugs for alcohol use disorders: a review of preclinical data
Ch’ng, S. S., & Lawrence, A. J. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1472763 · Cited by 14
Serum/glucocorticoid regulated kinase 1 (SGK1) in neurological disorders: pain or gain
Howard, P. G., Zou, P., Zhang, Y., Huang, F., Tesic, V., Wu, C. Y.-C., & Lee, R. H.-C. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114973 · Cited by 13
Gerhardt, S., Berhe, O., Moessnang, C., Horning, M., Kiefer, F., Tost, H., & Vollstädt-Klein, S. (2022) · Addiction Biology · doi:10.1111/adb.13251 · Cited by 12
Fox, M. E., Bucher, E. S., Johnson, J. A., & Wightman, R. M. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00210 · Cited by 11
Trautmann, S., Kräplin, A., Dieterich, R., Richter, J., & Muehlhan, M. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4979-4 · Cited by 16
Sampedro‐Piquero, P., Santín, L. J., & Castilla‐Ortega, E. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85280 · Cited by 16
Williams, M. A., Li, C., Kash, T. L., Matthews, R. T., & Winder, D. G. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.07.001 · Cited by 14
Mechanical Stimulation of the HT7 Acupuncture Point to Reduce Ethanol Self‐Administration in Rats
Kang, S.-Y., Kwon, O. S., Moon, J., Cho, S. J., Choi, K., Kim, J., Ahn, S.-H., & Ryu, Y. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/6578621 · Cited by 13
Dennis, T. S., Beck, K. D., Cominski, T. P., Bobzean, S. A. M., Kuzhikandathil, E. V., Servatius, R. J., & Perrotti, L. I. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.07.017 · Cited by 13
Critical roles for breathing in the genesis and modulation of emotional states
Homma, I., & Phillips, A. G. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-323-91534-2.00011-4 · Cited by 13
Fornili, K. S. (2022) · Journal of Addictions Nursing · doi:10.1097/jan.0000000000000484 · Cited by 11
Greener, M.-R., & Storr, S. J. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1166852 · Cited by 15
the CANSAS study group, Muehlhan, M., Höcker, A., Höfler, M., Wiedemann, K., Barnow, S., & Schäfer, I. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4595-8 · Cited by 12
McGrath, D. S., Sears, C. R., Fernandez, A., & Dobson, K. S. (2020) · Addiction Research & Theory · doi:10.1080/16066359.2020.1762867 · Cited by 13
Hopf, F. W., Sparta, D. R., & Bonci, A. (2011) · ILAR Journal · doi:10.1093/ilar.52.3.239 · Cited by 11
Inhibition of Glyoxalase 1 reduces alcohol self-administration in dependent and nondependent rats
de Guglielmo, G., Conlisk, D., Barkley‐Levenson, A. M., Palmer, A. A., & George, O. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.03.001 · Cited by 11
Rice, R. C., Gil, D. V., Baratta, A. M., Frawley, R. R., Hill, S. Y., Farris, S. P., & Homanics, G. E. (2023) · Neurobiology of Stress · doi:10.1016/j.ynstr.2023.100603 · Cited by 12
Hwa, L. S., Neira, S., Flanigan, M. E., Stanhope, C. M., Pina, M. M., Pati, D., Hon, O. J., Yu, W., Kokush, E., Calloway, R., et al. (2020) · eLife · doi:10.7554/elife.59709 · Cited by 11
RetractedKeller, B. N., Snyder, A. E., Coker, C. R., Aguilar, E. A., O’Brien, M. K., Lookfong, N. A., Bingaman, S. S., Arnold, A. C., Hajnal, A. S., & Silberman, Y. (2024) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15264 · Cited by 12
Neurodrinking: Is alcohol a substrate in a novel, endogenous synthetic pathway for norepinephrine?
Fitzgerald, P. J. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.02.025 · Cited by 10
Milik, E., Cudnoch‐Jędrzejewska, A., & Szczepanska‐Sadowska, E. K. (2015) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000269 · Cited by 11
West, A. M., Holleran, K. M., & Jones, S. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032080 · Cited by 10
Overnight deprivation from smoking disrupts amygdala responses to fear
Onur, O. A., Patin, A., Mihov, Y., Buecher, B., Stoffel‐Wagner, B., Schlaepfer, T. E., Walter, H., Maier, W., & Hurlemann, R. (2011) · Human Brain Mapping · doi:10.1002/hbm.21293 · Cited by 10
Diffusivity of the uncinate fasciculus in heroin users relates to their levels of anxiety
Wong, N. M. L., Cheung, S., Chan, C. C. H., Zeng, H., Liu, Y.-P., So, K., & Lee, T. M. C. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.48 · Cited by 10
Investigational therapies for the pharmacological treatment of alcoholism
Hillemacher, T., Leggio, L., & Heberlein, A. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.954037 · Cited by 10
Hoffman, J. L., Faccidomo, S., Taylor, S. M., DeMiceli, K. G., May, A. M., Smith, E. N., Whindleton, C. M., & Hodge, C. W. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06365-z · Cited by 6
C57 Mice Increase Wheel-Running Behavior following Stress: Preliminary Findings
Sibold, J., Hammack, S. E., & Falls, W. A. (2011) · Perceptual and Motor Skills · doi:10.2466/06.16.20.pms.113.5.605-618 · Cited by 9
Karel, P., van der Toorn, A., Vanderschuren, L. J. M. J., Guo, C. C.-G., Sadighi, M., Reneman, L., Dijkhuizen, R. M., Verheij, M. M. M., & Homberg, J. R. (2019) · Addiction Biology · doi:10.1111/adb.12722 · Cited by 9
Acupuncture for alcohol use disorder.
Chen, P., Li, J., Han, X., Grech, D., Xiong, M., Bekker, A., & Ye, J.-H. (2018) · PubMed Central · Cited by 9
Valle, M., Zertuche-Maldonado, T., & Bruera, E. D. (2018) · Medicina Paliativa · doi:10.1016/j.medipa.2016.12.002 · Cited by 8
Wang, L., Hu, F., Li, W., Li, Q., Li, Y., Zhu, J., Wei, X., Yang, J., Guo, J., Qin, Y., et al. (2021) · Psychological Medicine · doi:10.1017/s0033291721003937 · Cited by 8
Acute and chronic alcohol modulation of extended amygdala calcium dynamics
Roland, A. V., Chao, T.-H. H., Hon, O. J., Machinski, S. N., Sides, T. R., Lee, S. I., Shih, Y. I., & Kash, T. L. (2024) · Alcohol · doi:10.1016/j.alcohol.2024.02.004 · Cited by 9
Gereau, G. B., Torruella-Suárez, M. L., Sizer, S. E., Xia, M., Zhou, D., Wykoff, L. A., Teklezghi, A. T., Alvarez-Pamir, A., Boyt, K. M., Kash, T. L., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01830-5 · Cited by 10
Astroglia in the Vulnerability and Maintenance of Alcohol Use Disorders
Miguel-Hidalgo, J. J. (2021) · Advances in neurobiology · doi:10.1007/978-3-030-77375-5_11 · Cited by 8
Fujii, T., Onimaru, H., & Homma, I. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.06.008 · Cited by 8
Arnaiz, G. R. D. L., & Antonelli, M. C. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1849-5 · Cited by 8
Simons, R. M., Simons, J. S., Olson, D., Baugh, L. A., Magnotta, V. A., & Forster, G. L. (2016) · Psychology of Addictive Behaviors · doi:10.1037/adb0000200 · Cited by 7
Flanagan, J. C., Joseph, J. E., Nietert, P. J., Back, S. E., & McCrady, B. S. (2019) · Contemporary Clinical Trials · doi:10.1016/j.cct.2019.05.002 · Cited by 8
Ware, O. D., Strickland, J. C., Smith, K. E., Blakey, S. M., & Dunn, K. E. (2023) · Journal of Dual Diagnosis · doi:10.1080/15504263.2023.2260340 · Cited by 7
Comorbidity of Alcohol Use Disorders with Substance Use Disorders and Psychiatric Disorders
Zaorska, J., & Wojnar, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-32483-3_17 · Cited by 7
Huang, C., Wang, Y., Chen, P., Shan, Q., Wang, H., Ding, L., Bi, G., & Zhou, J. (2022) · Communications Biology · doi:10.1038/s42003-022-03260-9 · Cited by 7
Poudel, R., Tobia, M. J., Riedel, M. C., Salo, T., Flannery, J. S., Hill-Bowen, L. D., Dick, A. S., Laird, A. R., Parra, C. M., & Sutherland, M. T. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113867 · Cited by 7
The Impact of Alcohol-Induced Epigenetic Modifications in the Treatment of Alcohol use Disorders
Fanfarillo, F., Ferraguti, G., Lucarelli, M., Fuso, A., Ceccanti, M., Terracina, S. A., Micangeli, G., Tarani, L., & Fiore, M. (2023) · Current Medicinal Chemistry · doi:10.2174/0109298673256937231004093143 · Cited by 7
Acute prazosin administration does not reduce stressor reactivity in healthy adults
Kaye, J. T., Fronk, G. E., Zgierska, A. E., Cruz, M. R., Rabago, D., & Curtin, J. J. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05297-x · Cited by 7
Marusich, J. A., Gay, E. A., Watson, S. L., & Blough, B. E. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173935 · Cited by 6
Mechanisms Regulating Compulsive Drug Behaviors
Werner, C. T., Gancarz, A. M., & Dietz, D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812202-0.00010-5 · Cited by 7
Nelson, C. A., Brundage, J., Williams, B. M., Baldridge, J., Stockard, A. L., Bassett, C. H., Burger, B. J., Gunter, B. T., Payne, A. J., Yorgason, J. T., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12071593 · Cited by 6
Lepeak, L., Miracle, S. A., Ferragud, A., Seiglie, M. P., Shafique, S., Öztürk, Z., Minnig, M. A., Medeiros, G., Cottone, P., & Sabino, V. (2023) · eNeuro · doi:10.1523/eneuro.0424-23.2023 · Cited by 6
Lepreux, G., Henricks, A. M., Wei, G., Go, B. S., Erikson, C. M., Abella, R. M., Pham, A., & Walker, B. M. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173840 · Cited by 6
Nasseef, M. T., Devenyi, G. A., Mechling, A. E., Harsan, L. A., Chakravarty, M. M., Kieffer, B. L., & Darcq, E. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00643 · Cited by 8
Kim, J. S., & Martin‐Fardon, R. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14264 · Cited by 8
Neurodegenerative Diseases - Molecular Mechanisms and Current Therapeutic Approaches
Tunalı, N. E. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.83153 · Cited by 6
Jackson, M., Foret, B. L., Fontenot, J. A., Hasselschwert, D. L., Smith, J., Romero, E., & Smith, K. M. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25128 · Cited by 6
Shahidani, S., Jokar, Z., Alaei, H., & Reisi, P. (2022) · Synapse · doi:10.1002/syn.22256 · Cited by 6
Hyman, S. M., Richardson, G. B., Andrés-Hyman, R. C., & Fox, H. C. (2021) · Springer eBooks · doi:10.1007/978-3-319-19650-3_3855 · Cited by 6
Pan, Y., Cai, Z., Wang, Y., Zhang, J., Sheng, H., Shao, D., Cui, D., Guo, X., Zheng, P., & Lai, B. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150076 · Cited by 5
rTMS mechanisms for posttraumatic stress disorder treatment in a mouse model
Claverie, D., Cressant, A., Thomasson, J., Castellarin, C., Grandperret, V., Barbier, L., Troubat, R., Canini, F., Belzung, C., & El‐Hage, W. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.08.041 · Cited by 5
Acupuncture on the Stress‐Related Drug Relapse to Seeking
Roh, H. S., Park, B. R., Jang, E. Y., Kim, J. S., & Gwak, Y. S. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/5367864 · Cited by 6
Wang, X., Cochran, T. A., Hutchinson, M. R., Yin, H. H., & Watkins, L. R. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1429-6_12 · Cited by 5
Imaging a putative marker of brain cortisol regulation in alcohol use disorder
Verplaetse, T. L., Hillmer, A. T., Bhatt, S., Rusowicz, A., Li, S., Nabulsi, N., Matuskey, D., Huang, Y. H., McKee, S. A., & Cosgrove, K. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100609 · Cited by 5
Verplaetse, T. L., & McKee, S. A. (2016) · Current Addiction Reports · doi:10.1007/s40429-016-0115-x · Cited by 5
Oxytocin und die suchterhaltenden Mechanismen der Alkoholabhängigkeit
Faehrmann, T., Zernig, G., & Mechtcheriakov, S. (2017) · Neuropsychiatrie · doi:10.1007/s40211-017-0229-y · Cited by 5
Hill-Bowen, L. D., Riedel, M. C., Poudel, R., Salo, T., Flannery, J. S., Camilleri, J. A., Eickhoff, S. B., Laird, A. R., & Sutherland, M. T. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.26.966549 · Cited by 6
Functional evaluation of NK1 antagonism on cue reactivity in opiate dependence; An fMRI study
Fonville, L., Paterson, L. M., Herlinger, K., Hayes, A., Hill, R. G., Nutt, D., & Lingford-Hughes, A. R. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108564 · Cited by 4
Jewett, D. C., Liyanagamage, D. S. N. K., Avond, M. A. V., Anderson, M. A. B., Twaroski, K., Marek, M. A., James, K. F., Pal, T., Klockars, A., Olszewski, P. K., et al. (2022) · Nutrients · doi:10.3390/nu14050926 · Cited by 4
Patrono, E., Nishijo, H., Gasbarri, A., Pompili, A., & Tomaz, C. A. B. (2017) · Springer eBooks · doi:10.1007/978-3-319-53126-7_16 · Cited by 4
Prevalence and Correlates of Disability Among a Sample of Victimized Women on Probation and Parole
Smith, K. E., Bunting, A. M., Golder, S., Hall, M. T., Higgins, G. E., & Logan, T. (2019) · Journal of Correctional Health Care · doi:10.1177/1078345819833387 · Cited by 6
Bray, B., Clement, K. A., Bachmeier, D., Weber, M. A., & Forster, G. L. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107924 · Cited by 4
O’Sullivan, S. J., McIntosh-Clarke, D., Park, J. S., Vadigepalli, R., & Schwaber, J. S. (2021) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2021.739790 · Cited by 4
Peng, S., Huang, X., Xu, L., Cai, S., Chen, J., & Dong, H. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20064705 · Cited by 5
Latvala, A. (2011) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · Cited by 4
Modulation of HPA Axis Function for Treatment of Mood Disorders
Brothers, S. P., Wahlestedt, C., & Nemeroff, C. B. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734943-00276 · Cited by 4
Hyman, S. M., Richardson, G. B., Andrés-Hyman, R. C., & Fox, H. C. (2020) · Springer eBooks · doi:10.1007/978-3-319-16999-6_3855-1 · Cited by 4
Hoffman, J. L., Faccidomo, S., Taylor, S. M., DeMiceli, K. G., May, A. M., Smith, E. N., Whindleton, C. M., & Hodge, C. W. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.14.520457 · Cited by 4
Baidoo, N., Shaver, A., Ginson, B., Castellani, J., Lapointe, T., Wolter, M., & Leri, F. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110341 · Cited by 3
Perinatal fentanyl exposure drives enduring addiction risk and central amygdala gene dysregulation
Wood, C. P., Shin, Y., Balaguer, M. G., Campo, P., Dirik, S., Montoya, B. A., Cook, G. M. R., Palermo, G. M., Naghshineh, P. K., Morgan, A. A., et al. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110581 · Cited by 4
Metadata
- Authors
- Koob, G. F.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Koob, George F.
- ORCID
- Koob, George F.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 1293
- Pages
- 61-75
- ISSN
- 0006-8993 (ISSN-L)
- PMC
- PMC2774745
- OpenAlex
- W2010555262
- Cited by
- 388
- References
- 112
- Citations by year
- 2026: 11 · 2025: 10 · 2024: 22 · 2023: 17 · 2022: 20 · 2021: 24 · 2020: 31 · 2019: 33 · 2018: 34 · 2017: 20 · 2016: 25 · 2015: 28 · 2014: 24 · 2013: 24 · 2012: 20
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Brain Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Alcohol Abuse and Alcoholism (R01AA008459, AA-06420, AA-08459, P50AA006420, R37AA008459, P60AA006420)
- National Institute on Drug Abuse (DA04043, DA04398, R01DA004398, R01DA004043)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 26741, P01DK026741)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- drug addiction, extended amygdala, corticotropin-releasing factor, norepinephrine, central amygdala, bed nucleus of the stria terminalis, nucleus accumbens shell, negative reinforcement, emotional arousal, relapse, motivated behavior
- MeSH terms
- Amygdala, Animals, Compulsive Behavior, Corticotropin-Releasing Hormone, Humans, Hypothalamo-Hypophyseal System, Motivation, Norepinephrine, Pituitary-Adrenal System, Stress, Psychological, Substance Withdrawal Syndrome, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review